Human + Chlamydia HSP-60

Measures antibodies against 32 different pathogens that may lead to autoimmune reactivities, including oral pathogens, gut pathogens, Mycoplasma, Chlamydia, Mycobacterium avium, Candida albicans, mycotoxin-producing molds (Aspergillus, Penicillium, Stachybotrys), EBV, CMV, HHV-6, and the agent and co-infections of Lyme disease. Detects possible associations between different bacteria, viruses, parasites, yeasts, and molds with more than 80 different autoimmune diseases due to cross-reactivity and molecular mimicry. It can also be used to monitor the effectiveness of various protocols in the management of autoimmune disorders triggered by pathogens. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2006, 2009, 2014, 2015, 2018, 2021, and 2024.